NCT00079183View on ClinicalTrials.gov

Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

July 31, 2009

Study Completion Date

June 10, 2010

Conditions
Graft Versus Host Disease
Interventions
DRUG

sirolimus

Given PO

Trial Locations (1)

98109

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00079183 - Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment | Biotech Hunter | Biotech Hunter